Background: Pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are common pelvic floor disorders with multifactorial etiology. This study aimed to identify demographic, anthropometric, and obstetric factors associated with POP and SUI. Methods: A retrospective cross-sectional study was conducted among 5,477 women attending a tertiary urogynecological outpatient clinic between 2016 and 2025. The study group included 4,333 women diagnosed with POP or SUI, while 1,144 women with other gynecological conditions served as controls. Associations between age, body mass index (BMI), smoking, and obstetric history were evaluated using multivariable logistic regression and the U-Smile predictive method. Results: Increasing age was independently associated with a higher risk of pelvic floor disorders (OR = 1.02; 95% CI: 1.01–1.02; p < 0.0001). Overweight was associated with a reduced likelihood of POP/SUI compared with normal BMI (OR = 0.85; 95% CI: 0.73–1.00; p = 0.0444). Each additional full-term pregnancy was associated with a 35% reduction in the odds of pelvic floor disorders (OR = 0.65; 95% CI: 0.60–0.69; p < 0.0001). Underweight, obesity, preterm birth, miscarriage, and smoking were not independent predictors. Conclusions: Age, overweight status, and the number of full-term pregnancies were the strongest independent predictors of POP and SUI. Further studies are needed to clarify the unexpected protective associations observed for overweight and term pregnancies.
Objectives: This cross-sectional study aimed to evaluate the associations between fundamental metabolic markers, specifically fasting glucose and total cholesterol, and cognitive performance in a primary care population, continuing previous analyses focused on subclinical vascular parameters. Methods: The study included 137 primary care patients who completed neuropsychological assessments (Addenbrooke’s Cognitive Examination-III (ACE-III) and Mini-Mental State Examination (MMSE)) and a clinical interview. Fasting glucose and total cholesterol levels were extracted from their medical records. Results: Based on the MMSE, 26 participants (19.0%) had mild cognitive impairment (MCI), and 8 (5.8%) had neurocognitive disorders. Univariate regression analysis revealed that fasting glucose was significantly and inversely associated with the total ACE-III score (B = 0.277; 95% CI: −0.441 to −0.113; p = 0.001) and the M-ACE subscale score (B = 0.175; 95% CI: −0.342 to −0.008; p = 0.046). Conversely, total cholesterol showed a positive association with both the overall ACE-III score (B = 0.173; 95% CI: 0.006 to 0.340; p = 0.046) and the M-ACE score (B = 0.219; 95% CI: 0.053 to 0.385; p = 0.011). A potential clinical paradox was observed, as among patients with established cardiovascular disease, lower total cholesterol (177.39 vs. 201.58 mg/dL, p = 0.047) co-occurred with poorer cognitive outcomes (mean ACE-III: 81.47 vs. 87.62, p = 0.003), possibly reflecting a confounding effect of statin therapy. Standard MMSE scores did not correlate significantly with any evaluated metabolic parameters. Conclusions: Fasting glucose and total cholesterol are cross-sectionally associated with cognitive performance in this primary care cohort, whereas standard MMSE scores did not exhibit significant metabolic correlations. Given the exploratory, cross-sectional design, these findings are strictly hypothesis-generating and do not establish clinical screening utility or causality. The disparate patterns of association between the ACE-III and MMSE suggest that these screening tools may capture metabolism-related cognitive variations differently, highlighting the need for prospective longitudinal research.
Objectives: This study aimed to evaluate the associations between fundamental metabolic markers—specifically fasting glucose and total cholesterol—and cognitive performance in a primary care population, continuing previous analyses focused on subclinical vascular parameters. Methods: The study included 137 primary care patients who completed neuropsychological assessments (Addenbrooke’s Cognitive Examination-III/ACE-III and Mini-Mental State Examination/MMSE) and a clinical interview. Fasting glucose and total cholesterol levels were extracted from their medical records. Results: Based on the MMSE, 26 participants (19.0%) had mild cognitive impairment (MCI) and 8 (5.8%) had neurocognitive disorders. Fasting glucose showed a significant negative correlation with the total ACE-III score, indicating poorer global cognition. Conversely, total cholesterol exhibited a weak positive correlation with the ACE-III score, a paradox likely reflecting the frequent use of lipid-lowering therapies in this group. Standard MMSE scores did not correlate significantly with any evaluated metabolic parameters. Conclusions: Elevated fasting glucose is associated with early cognitive decline, suggesting its utility in routine primary care screening for MCI risk. Furthermore, more comprehensive tools like the ACE-III are essential, as the standard MMSE fails to capture these subtle metabolic-related cognitive deficits.